This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Breast12, CAPItello-290, and ICARUS-BREAST01

544 views
October 4, 2024

Chapters

DESTINY-Breast12: Efficacy in Brain Metastases

00:00

T-DXd's Impact & Treatment Considerations

03:02

Managing T-DXd Side Effects & Steroid Use

05:14

Exploring ADCs in HER2-Low Breast Cancer

08:02

CAPItello-290: AKT Inhibitor in Triple Negative BC

09:50

Challenges in Targeting Biomarkers in TNBC

09:54

ICARUS-BREAST01: HER3-DXd in HR+ Breast Cancer

14:47

Future of ADCs & HER3-DXd's Place

16:48

Comments 0
Login to view comments. Click here to Login